Barrett Cancer Center

Cincinnati, Ohio 45267-0526

0 studies enrolling now · 36 studies all time

What they study most

Anemia, Brain and Central Nervous System Tumors, Breast Cancer, Cancer of the Bile Duct, Cardiac Toxicity, Cervical Cancer, Colorectal Cancer, Endometrial Cancer, Esophageal Cancer, Fallopian Tube Cancer, Gallbladder Cancer, Gastric Cancer

Studies at this site

• Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study — Running, not enrolling
• Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy — Completed
• Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer — Completed
• Melatonin and Radiation Therapy in Treating Patients With Brain Metastases — Completed
• Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme — Completed
• Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer — Withdrawn before enrolling
• Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord — Completed
• Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma — Completed
• Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer — Completed
• Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer — Completed
• Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer — Completed
• Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme — Completed
• SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial — Completed
• S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome — Completed
• S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia — Completed
• S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia — Completed
• Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas — Completed
• S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer — Stopped early
• Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme — Status unconfirmed
• Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma — Withdrawn before enrolling
• Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer — Completed
• BMS-247550 in Treating Patients With Advanced Pancreatic Cancer — Completed
• Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer — Completed
• Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer — Stopped early
• Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus — Stopped early
• Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer — Stopped early
• S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer — Completed
• S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer — Completed
• S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer — Completed
• Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia — Completed
• S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors — Completed
• S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer — Withdrawn before enrolling
• S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer — Stopped early
• TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer — Completed
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer — Completed
• Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen — Completed